FDA Approvals

Date Posted
Article Title
2/4/2009
Vectical Ointment Approved for Psoriasis

Vitamin D3 is active ingredient

2/2/2009
Kapidex Approved for Acid Reflux

A reformulated version of Prevacid

1/28/2009
Gelnique Approved for Overactive Bladder

A topical gel for treating symptoms

1/16/2009
Riastap Approved for Rare Blood Disorder

Congenital fibrinogen deficiency can cause uncontrolled bleeding

1/15/2009
Savella Approved for Fibromyalgia

Expected in pharmacies by March

1/13/2009
Diagnostic Approved to Detect C. diff

An infection commonly acquired in hospitals

12/31/2008
Nucleic Acid Test Screens for HIV

In donated blood and tissue

12/29/2008
Degarelix Approved for Advanced Prostate Cancer

Suppresses testosterone production

12/22/2008
Zolpimist Approved for Insomnia

Oral spray contains Ambien's active ingredient

12/22/2008
Gleevec Approved for Use After Cancer Surgery

Drug first sanctioned in 2001

12/19/2008
Mozobil Boosts Stem Cells Before Bone Marrow Transplants

Could help people with certain forms of blood cancer

12/16/2008
TriLipix Approved to Help Lower Cholesterol

To be used alone, or in combination with a statin

11/24/2008
Promacta Approved for Rare Blood Disorder

Affects about 60,000 people in United States

11/21/2008
11/12/2008
Early Onset Approved for ADHD Drug

30-minute onset of action for Focalin XR

10/17/2008
Ontak Approved to Treat T-Cell Lymphoma

Targets specific receptor on cancer cells

10/13/2008
NeuroStar Depression Therapy Cleared

Targets nerve cells with magnetic pulses

10/10/2008
Kogenate FS Prevents Joint Damage in Young Hemophiliacs

Hemophilia A affects about 15,000 in the U.S.

10/9/2008
Rapaflo Approved for Enlarged Prostate

The leading reason men visit urologists

9/29/2008
'Superbug' Test Detects MRSA Faster

Existing diagnostics can take up to 3 days